ChrysCapital Fund X
ChrysCapital Fund X is the manager’s tenth India-focused private-equity vehicle, closed at approximately US$2.2 billion in 2025. Public filings identify Fund X in investments involving ILJIN Electronics, Nash Industries and Novartis India, while the manager’s current mandate spans growth and control opportunities across healthcare, manufacturing, consumer and enterprise technology.
At a glance
- Founded
- 2024
- Footprint
- New Delhi / India
- Stage
- Growth and control private equity
Research profile
Read the manager in sequence.
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
ChrysCapital Fund X uses a growth and control private equity approach across Healthcare, manufacturing, consumer, enterprise technology.
Current evidence
Fund X was identified as an acquirer or investor in 2025–2026 filings involving ILJIN Electronics, Nash Industries and Novartis India, following ChrysCapital’s November 2025 US$2.2 billion close.
Strategy
Growth and control private equity
Sector focus
Healthcare, manufacturing, consumer, enterprise technology
Current signal
Fund X was identified as an acquirer or investor in 2025–2026 filings involving ILJIN Electronics, Nash Industries and Novartis India, following ChrysCapital’s November 2025 US$2.2 billion close.
Next step
Need this manager reviewed against your mandate?
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.